Gene · 3587
Papers3,503
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,503
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct functions and transcriptional signatures in orally induced regulatory T cell populations. | Front Immunol | 2023 | 37954612 | PubTator, text mining | PubMed |
| Revisiting regulatory T cells as modulators of innate immune response and inflammatory diseases. | Front Immunol | 2023 | 37928540 | PubTator, text mining | PubMed |
| The extracellular polysaccharide inhibit porcine epidemic diarrhea virus with extract and gene editing Lacticaseibacillus. | Microb Cell Fact | 2023 | 37924089 | PubTator, text mining | PubMed |
| Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade. | J Immunother Cancer | 2023 | 37918918 | PubTator, text mining | PubMed |
| FGL1-LAG3 axis impairs IL-10-Producing regulatory T cells associated with Systemic lupus erythematosus disease activity. | Heliyon | 2023 | 37916085 | PubTator, text mining | PubMed |
| [Analysis of a child with Very early onset inflammatory bowel disease due to compound heterozygous variants of IL10RA and DUOX2 genes]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2023 | 37906150 | PubTator, text mining | PubMed |
| Association of intestinal dysbiosis with susceptibility to multiple sclerosis: Evidence from different population studies (Review). | Biomed Rep | 2023 | 37901876 | PubTator, text mining | PubMed |
| CD28/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response. | J Exp Clin Cancer Res | 2023 | 37898752 | PubTator, text mining | PubMed |
| Role of Resolvins in Inflammatory and Neuropathic Pain. | Pharmaceuticals (Basel) | 2023 | 37895837 | PubTator, text mining | PubMed |
| Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4. | Int J Mol Sci | 2023 | 37894816 | PubTator, text mining | PubMed |
| TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. | Biomedicines | 2023 | 37893178 | PubTator, text mining | PubMed |
| Regulation of HHLA2 expression in kidney cancer and myeloid cells. | BMC Cancer | 2023 | 37891555 | PubTator, text mining | PubMed |
| Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review). | Int J Oncol | 2023 | 37888583 | PubTator, text mining | PubMed |
| Higher expression of PLEK and LY86 as the potential biomarker of carotid atherosclerosis. | Medicine (Baltimore) | 2023 | 37861500 | PubTator, text mining | PubMed |
| In silico prediction of deleterious non-synonymous SNPs in STAT3. | Asian Biomed (Res Rev News) | 2023 | 37860678 | PubTator, text mining | PubMed |
| Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. | Mol Cancer | 2023 | 37833788 | PubTator, text mining | PubMed |
| Age-related influence on DNA damage, proteomic inflammatory markers and oxidative stress in hospitalized COVID-19 patients compared to healthy controls. | Redox Biol | 2023 | 37832397 | PubTator, text mining | PubMed |
| The role of CD4+ T cells in tumor and chronic viral immune responses. | MedComm (2020) | 2023 | 37829505 | PubTator, text mining | PubMed |
| Identification of two immune subtypes and four hub immune-related genes in ovarian cancer through multiple analysis. | Medicine (Baltimore) | 2023 | 37800814 | PubTator, text mining | PubMed |
| Large-scale plasma proteomics comparisons through genetics and disease associations. | Nature | 2023 | 37794188 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3587/papers?page=13